New Alzheimer’s Drug on the Horizon
The anticipated release of results from a worldwide human trial for a new Alzheimer’s drug has generated a lot of excitement in the...
A Psychedelic Approach to Mental Health
A first of its kind trial was given the green light last week, as Health Canada provided a “No Objection Letter” for the evaluation of...
Everything you need to know about maximizing your pharmaceutical sales force!
Given the ever-changing nature of the pharmaceutical industry, it’s no surprise the role of the sales force must adapt to continue to...
Crohn's and Colitis Awareness Month: Treatment Advances in CD
Crohn’s disease (CD) is a type of inflammatory bowel disorder with a Canadian prevalence of approximately 319 per 100,000 individuals. CD...
Approval of new imaging agent set to help illuminate prostate cancer detection
Prostate cancer is the fourth most common cancer in Canada, with 1 in 9 men being diagnosed with the disease in their lifetime. Although...
A “smart” approach to monitoring drug levels in real-time
Throughout the COVID-19 pandemic, many physicians having been looking to leverage smart technology to help monitor and track the health...
Snapshot of Select Canadian COVID-19 Trials
Canadian researchers are active amidst the COVID-19 pandemic, investigating drugs and vaccines for the treatment and prevention of this...
FDA Approves Artificial Intelligence for Detecting Suspicious Mammography Lesions
This week Zebra Medical announced the FDA approval for their HealthMammo artificial intelligence system. This system scans mammograms and...
World’s Largest Cancer Conference Goes Virtual Next Week
The American Society of Clinical Oncology (ASCO) Annual Meeting is the world’s largest cancer research conference. It was originally...
The Impact of COVID-19 on Clinical Trial Research
Amid the COVID-19 pandemic, clinical trials are running into challenges with how they conduct their research. These challenges may arise...